MedPath

Evaluation of a Decision Support Tool

Not Applicable
Conditions
Decision Making, Shared
Hypertension
Medication Adherence
Patient-Centered Outcomes Research
Interventions
Behavioral: Interview Only
Behavioral: Control
Behavioral: Interview plus decision support tool
Registration Number
NCT02060981
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

Investigators will conduct a randomized trial with patients, through one-on-one interviews, to evaluate their understanding of and willingness to use a decision support tool and to determine if receiving and discussing the decision support tool improves the likelihood that a patient is adherent to a new antihypertensive medication.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
140
Inclusion Criteria
  • does not pick up a prescription for a new antihypertensive medication within 14 days as identified by CVS pharmacy, their retail pharmacy provider.
  • High blood pressure diagnosis
Exclusion Criteria
  • under age 25.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Interview onlyInterview OnlyPatients will be asked to participate in an interview regarding their views on hypertension and taking medications to treat hypertension.
ControlControlControl group patients will then be mailed an American Heart Association brochure regarding hypertension and a brief, 5-question, paper-based survey. These patients will be asked to review the brochure, complete the survey, and mail it back to the research team using a self-addressed stamped envelope.
Interview plus decision support toolInterview plus decision support toolPatients will be asked to participate in an interview regarding their views on hypertension and taking medications to treat hypertension, and to provide feedback regarding a new tool for helping patients learn more about their medications. Interview plus patients' index date for follow-up is the date of the scheduled interview.
Primary Outcome Measures
NameTimeMethod
Cumulative incidence of antihypertensive medication fills6 months

The proportion of patients in each group who picked up a prescription for an antihypertensive medication in any class during the follow-up period. Investigators will calculate cumulative incidences among all patients, whether or not they successfully completed the interview or returned the paper-based survey (Intention to Treat) and among only those patients who did complete the interview or returned the paper-based survey (As Treated).

Secondary Outcome Measures
NameTimeMethod
Patient Interviews5 months

One-on-one structured interviews will ask about participants' preferences, attitudes and beliefs regarding primary adherence and/or use of a decision support tool.

Trial Locations

Locations (1)

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath